Adc Therapeutics Sa (ADCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 04-2009 | 03-2009 | 01-2009 | 12-2008 | 10-2008 | |
| Sales | 275,100 | 256,600 | 254,300 | 299,700 | 338,500 |
| Cost of Goods | 185,000 | 173,800 | 175,600 | 225,400 | 249,700 |
| Gross Profit | 90,100 | 82,800 | 78,700 | 74,300 | 88,800 |
| Operating Expenses | 92,500 | 497,600 | 505,500 | 99,200 | 100,400 |
| Operating Income | -2,400 | -414,000 | -426,200 | -24,500 | -10,900 |
| Other Income | -5,800 | -23,000 | -20,300 | -28,000 | -30,300 |
| Pre-tax Income | -8,200 | -437,000 | -446,500 | -52,500 | -41,200 |
| Income Tax | 1,400 | -3,000 | -4,000 | -4,100 | -100 |
| Net Income Continuous | -9,600 | -434,000 | -442,500 | -48,400 | -41,100 |
| Net Income Discontinuous | -1,300 | -9,700 | -300 | -2,000 | -5,600 |
| Minority Interests | N/A | -600 | N/A | -700 | N/A |
| Net Income | $-10,900 | $-443,100 | $-442,800 | $-49,700 | $-46,000 |
| EPS Basic Total Ops | -0.11 | -4.59 | -4.45 | -0.47 | -0.40 |
| EPS Basic Continuous Ops | -0.10 | -4.49 | -4.45 | -0.46 | -0.35 |
| EPS Basic Discontinuous Ops | -0.01 | -0.10 | 0.00 | -0.01 | -0.05 |
| EPS Diluted Total Ops | -0.11 | -4.59 | -4.45 | -0.47 | -0.40 |
| EPS Diluted Continuous Ops | -0.10 | -4.49 | -4.45 | -0.46 | -0.35 |
| EPS Diluted Discontinuous Ops | -0.01 | -0.10 | 0.00 | -0.01 | -0.05 |
| EBITDA(a) | $-337,200 | $-449,600 | $-461,800 | $399,800 | $34,000 |